Correlation Between Interpace Biosciences and Genetic Technologies

Can any of the company-specific risk be diversified away by investing in both Interpace Biosciences and Genetic Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Interpace Biosciences and Genetic Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Interpace Biosciences and Genetic Technologies, you can compare the effects of market volatilities on Interpace Biosciences and Genetic Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Interpace Biosciences with a short position of Genetic Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Interpace Biosciences and Genetic Technologies.

Diversification Opportunities for Interpace Biosciences and Genetic Technologies

-0.54

Correlation Coefficient

Interpace Biosciences  Genetic Technologies

Excellent diversification

The 3 months correlation between Interpace and Genetic is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Interpace Biosciences and Genetic Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genetic Technologies and Interpace Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Interpace Biosciences are associated (or correlated) with Genetic Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genetic Technologies has no effect on the direction of Interpace Biosciences i.e., Interpace Biosciences and Genetic Technologies go up and down completely randomly.

Pair Corralation between Interpace Biosciences and Genetic Technologies

If you would invest  220.00  in Interpace Biosciences on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Interpace Biosciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	1.56%
Values	Daily Returns

Interpace Biosciences  vs.  Genetic Technologies

Interpace Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Interpace Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Interpace Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Genetic Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genetic Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Interpace Biosciences and Genetic Technologies

The main advantage of trading using opposite Interpace Biosciences and Genetic Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Interpace Biosciences position performs unexpectedly, Genetic Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genetic Technologies will offset losses from the drop in Genetic Technologies' long position.

The idea behind Interpace Biosciences and Genetic Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.